BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28971497)

  • 1. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.
    Zhou CK; Stanczyk FZ; Hafi M; Veneroso CC; Lynch B; Falk RT; Niwa S; Emanuel E; Gao YT; Hemstreet GP; Zolfghari L; Carroll PR; Manyak MJ; Sesterhenn IA; Levine PH; Hsing AW; Cook MB
    Prostate; 2017 Dec; 77(16):1573-1582. PubMed ID: 28971497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
    J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations.
    Cook MB; Stanczyk FZ; Wood SN; Pfeiffer RM; Hafi M; Veneroso CC; Lynch B; Falk RT; Zhou CK; Niwa S; Emanuel E; Gao YT; Hemstreet GP; Zolfghari L; Carroll PR; Manyak MJ; Sesterhann IA; Levine PH; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1660-1666. PubMed ID: 28830872
    [No Abstract]   [Full Text] [Related]  

  • 4. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum androgens: associations with prostate cancer risk and hair patterning.
    Demark-Wahnefried W; Lesko SM; Conaway MR; Robertson CN; Clark RV; Lobaugh B; Mathias BJ; Strigo TS; Paulson DF
    J Androl; 1997; 18(5):495-500. PubMed ID: 9349747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormones and hair patterning in men: a role for insulin-like growth factor 1?
    Signorello LB; Wuu J; Hsieh Cc; Tzonou A; Trichopoulos D; Mantzoros CS
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):200-3. PubMed ID: 10025745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer.
    Salmon C; Mesidor M; Rousseau MC; Richard H; Weiss D; Spence AR; Parent ME
    Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):143-150. PubMed ID: 37851110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer.
    Gershman B; Shui IM; Stampfer M; Platz EA; Gann PH; Sesso HL; DuPre N; Giovannucci E; Mucci LA
    Eur Urol; 2014 Apr; 65(4):683-9. PubMed ID: 23340241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal profile of men with premature balding.
    Stárka L; Cermáková I; Dusková M; Hill M; Dolezal M; Polácek V
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):24-8. PubMed ID: 14758568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male pattern baldness in relation to prostate cancer risks: an analysis in the VITamins and lifestyle (VITAL) cohort study.
    Zhou CK; Littman AJ; Levine PH; Hoffman HJ; Cleary SD; White E; Cook MB
    Prostate; 2015 Mar; 75(4):415-23. PubMed ID: 25492530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating steroid hormones and the risk of prostate cancer.
    Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male Pattern Baldness in Relation to Prostate Cancer-Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study.
    Zhou CK; Levine PH; Cleary SD; Hoffman HJ; Graubard BI; Cook MB
    Am J Epidemiol; 2016 Feb; 183(3):210-7. PubMed ID: 26764224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness?
    Lis-Święty A; Arasiewicz H; Ranosz-Janicka I; Brzezińska-Wcisło L
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1815-1818. PubMed ID: 29237093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocrinology of baldness.
    Batrinos ML
    Hormones (Athens); 2014; 13(2):197-212. PubMed ID: 24776620
    [No Abstract]   [Full Text] [Related]  

  • 16. Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression.
    Graff RE; Meisner A; Ahearn TU; Fiorentino M; Loda M; Giovannucci EL; Mucci LA; Pettersson A
    Br J Cancer; 2016 Apr; 114(8):939-44. PubMed ID: 26986253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.
    Black A; Pinsky PF; Grubb RL; Falk RT; Hsing AW; Chu L; Meyer T; Veenstra TD; Xu X; Yu K; Ziegler RG; Brinton LA; Hoover RN; Cook MB
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2374-82. PubMed ID: 25178985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium and Sex Steroid Hormones in a U.S. Nationally Representative Sample of Men: A Role for the Link between Selenium and Estradiol in Prostate Carcinogenesis?
    Van Hemelrijck M; Sollie S; Nelson WG; Yager JD; Kanarek NF; Dobs A; Platz EA; Rohrmann S
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):578-583. PubMed ID: 30482876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial.
    Chadid S; Barber JR; Nelson WG; Gurel B; Lucia MS; Thompson IM; Goodman PJ; Stanczyk FZ; Parnes HL; Lippman SM; De Marzo AM; Platz EA
    Prostate; 2020 Aug; 80(11):895-905. PubMed ID: 32506665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.
    Kristal AR; Till C; Tangen CM; Goodman PJ; Neuhouser ML; Stanczyk FZ; Chu LW; Patel SK; Thompson IM; Reichardt JK; Hoque A; Platz EA; Figg WD; Van Bokhoven A; Lippman SM; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1823-32. PubMed ID: 22879203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.